ArticleBMC oral health2026
PanMB2-Net: a deep learning framework for preoperative MB2 canal risk assessment on panoramic radiographs.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesThis study aimed to develop and validate a clinically motivated artificial intelligence framework for preoperative risk assessment of the second mesiobuccal (MB2) canal in maxillary first molars using panoramic radiographs. MATERIALS AND
methodsA total of 388 panoramic radiographs were retrospectively collected. Stage 1 used YOLOv5 to localize maxillary first molars and crop tooth-level regions of interest. Stage 2 applied Panoramic-based MB2 Prediction Network (PanMB2-Net) (ResNet50 with gray-guided attention, receptive field block, contrastive regularization, and Sobel edge loss) for MB2 classification. Data were split 80/20 at the image level for training/validation. Detection was assessed by localization accuracy; classification via accuracy, precision, recall, and F1-score. Ablation studies and class activation heatmaps were used for validation and visualization.
resultsPanMB2-Net achieved 72.9% validation accuracy, exceeding the 50% statistical baseline for the balanced dataset. For MB2 prediction, precision, recall, and F1-score were 0.687, 0.673, and 0.679, respectively. Comparative experiments showed consistent improvements over common convolutional and transformer-based baselines, and ablation studies confirmed the complementary contributions of gray-guided attention, multi-scale enhancement, and auxiliary regularization losses.
conclusionsPanMB2-Net is a feasible clinically aligned tool for MB2 risk assessment on panoramic radiographs. Although not a replacement for CBCT, it may support preoperative decision-making by highlighting cases that warrant increased attention without additional radiation exposure or examination cost. CLINICAL RELEVANCE: PanMB2‑Net provides preoperative MB2 canal risk assessment from routine panoramic radiographs before endodontic therapy, identifying teeth that merit closer exploration or CBCT, supporting decisions without added radiation or cost. It augments clinician judgment and CBCT rather than replacing them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.